Latest filing published 07 Nov 2023 for Korro Bio, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Nessan Bermingham: trading record in brief
This profile gathers the share dealings of Nessan Bermingham across 3 companies, led by Intellia Therapeutics, Inc., F-star Therapeutics, Inc. and Korro Bio, Inc. The record holds 12 filings, for trades running from 11 May 2016 to 3 November 2023.
The open-market record consists of 5 sales worth €5.9M, with no purchase. Outside the open market, there are 4 share grants.
The latest filing, published on 7 November 2023, reports a share grant in Korro Bio, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Nessan Bermingham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,114 sharesCommon StockSEC:0000950170-23-060608:0
- 97,547 shares@ US$7.12100.0% of flowCommon StockSEC:0000899243-23-007657:0
- 16,875 shares0Common StockSEC:0001209191-21-053233:0
3 of 3 declarations
